In-stent Restenosis Clinical Trial
Official title:
RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent). A Prospective, Multicenter and Randomized Clinical Trial
Treatment of patients with drug-eluting stent restenosis remains a challenge. This study will assess which interventional strategy (paclitaxel-eluting balloon vs everolimus-eluting stent) is superior in the treatment of patients suffering from drug-eluting stent restenosis.
Treatment of patients with drug-eluting stent restenosis remains a major clinical and
technical challenge. Currently, drug-eluting stents are widely used in the management of
these patients. Recently, the value of the paclitaxel-eluting balloon in this clinical
setting has been suggested. However, there is only scarce observational data on the value of
this new balloon in patients with drug-eluting stent restenosis.
This prospective, multicenter, randomized clinical trial will compare two different
interventional strategies (namely, paclitaxel-eluting balloon vs everolimus-eluting stent)
in the treatment of patients with drug-eluting stent restenosis.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00341562 -
Genomics of In-Stent Restenosis
|
N/A | |
| Completed |
NCT05509296 -
Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease
|
N/A | |
| Not yet recruiting |
NCT06090890 -
Anti-inflammatory Therapy for Recurrent In-stent Restenosis
|
Phase 4 | |
| Active, not recruiting |
NCT00998439 -
Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter
|
Phase 2 | |
| Active, not recruiting |
NCT05731700 -
CVT-ISR First in Human Trial for Coronary In-Stent Restenosis
|
N/A | |
| Completed |
NCT03260517 -
The PREVAIL Study
|
N/A | |
| Not yet recruiting |
NCT03588962 -
Metal Allergy In-Stent Restenosis Study
|
N/A | |
| Completed |
NCT00393315 -
P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses
|
Phase 2 | |
| Recruiting |
NCT03874481 -
The Effect of Sleep Quality on Coronary Artery Disease and In Stent Restenosis
|
||
| Active, not recruiting |
NCT01127958 -
DARE-trial: A Trial Studying the Effect of the SeQuent Please Drug-eluting Balloon Compared to the Xience Prime Drug-eluting Stent for the Treatment of Stenosis of an Earlier Implanted Stent.
|
N/A | |
| Active, not recruiting |
NCT04647253 -
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)
|
Phase 3 | |
| Active, not recruiting |
NCT03529006 -
Absorb Bioresorbable Scaffold vs. Drug Coated Balloon for Treatment Of In-Stent-Restenosis
|
N/A | |
| Completed |
NCT00485030 -
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
|
Phase 4 | |
| Not yet recruiting |
NCT03809754 -
Optical Coherence Tomography Guided Percutaneous Coronary Intervention for Drug-eluting In-stent Restenosis
|
N/A | |
| Completed |
NCT00916279 -
PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05473884 -
Lesion Preparation in Femoropopliteal Artery Occlusion Disease
|
||
| Active, not recruiting |
NCT01239953 -
RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)
|
Phase 4 | |
| Not yet recruiting |
NCT06148441 -
Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention
|
||
| Completed |
NCT05512832 -
In-stent Restenosis and Pericoronary Fat Attenuation Index
|
||
| Recruiting |
NCT03521843 -
LDD in Treatment of Femoropopliteal ISR
|
N/A |